Advertisement Covidien introduces Parietex ProGrip hernia repair mesh - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Covidien introduces Parietex ProGrip hernia repair mesh

Covidien, a provider of healthcare products, has announced that its surgical devices business unit has launched Parietex ProGrip mesh to customers throughout the US and Europe.

Parietex ProGrip mesh is said to be the first bicomponent mesh composed of monofilament polyester and a resorbable polylactic acid gripping system that facilitates a tension-free repair.

The mesh’s self-gripping feature provides secure fixation, reducing or possibly eliminating the need to place supplemental fixation, the company said. The final decision on fixating Parietex ProGrip mesh remains with the surgeon, based on the size of the defect, the hernia position and the quality of the anatomical structures.

According to Covidien, the Parietex ProGrip mesh, made of lightweight, hydrophilic polyester, provides optimal porosity, which, in turn, fosters better tissue in-growth and may reduce pain. In addition, by working with the body’s natural systems, this new product reportedly reduces the amount of foreign material left in the body.

Scott Flora, president of surgical devices at Covidien, said: “Covidien offers a complete hernia solution to our customers. We provide the optimal hernia repair product for individual patient needs, including biologic implants, synthetic mesh, fixation and dissection devices.”